We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

32 hedge funds and large institutions have $58.3M invested in Axcella Health Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less funds holding

Funds holding: 3332 (-1)

16% less capital invested

Capital invested by funds: $69.2M → $58.3M (-$10.8M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
6
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

AXLA Hedge Fund Activity: Q3 2022 in Review

32 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2022, worth a combined $58.3M — down 16% from $69.2M a quarter earlier.

Fund positioning in AXLA was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 8 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $91.7K. The largest seller was HighTower Advisors, exiting entirely with an estimated $22K sold.

  • 32 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2022, down from 33 in Q2 2022.
  • Funds reported $58.3M of Axcella Health Inc. Common Stock stock for Q3 2022, down 16% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of 0 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q3 2022 was Susquehanna International Group, an estimated $91.7K added.
  • The largest Axcella Health Inc. Common Stock seller in Q3 2022 was HighTower Advisors, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2022.